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Abstract: Enantiopure  exo-4-nitro-3,5-diphenylproline reacts with aldehydes and electrophilic alkenes, in good yields, 
through a multicomponent 1,3-dipolar cycloaddition where the intermediate azomethine ylide is generated by the 
decarboxylative route. The reactions with maleimides afford diastereoselectively nitropyrrolizidines. Dimethyl fumarate 
and 1,2-bis(phenylsulfonyl)ethylene also give variable mixtures of diastereoisomeric nitropyrrolizidines. The replacement 
of aldehydes by phenyl-3-buten-2-one also affords satisfactory results with high diastereoselection although in lower 
yields. The stereochemical outcome is studied and defined according to the absolute configuration of the resulting 
cycloadducts.   
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1. INTRODUCTION 
Pyrrolizidine alkaloids (PAs) constitute one of the most 
attractive families of natural products [1] due to their wide 
and diverse set of biological applications. However, 
hepatotoxicity, especially veno-occlusive disease, is the most 
serious result of ingestion of PAs [2,3]. On the other hand, 
PAs are not all toxic and the range of potential activity is very 
promising in many scientific areas [4]. Although the most 
abundant are hydroxylated PAs, non-hydroxylated natural 
pyrrolizidines shown in Figure 1 also exhibit potent 
glycosidase inhibition apart from other biological properties 
[5].  
 
Figure 1. Non hydroxylated naturally occurring PAs. 
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There are several approaches to the synthesis of these 
alkaloids [1,6] but the most straightforward route consists in 
the employment of 1,3-dipolar cycloaddition (1,3-DC) of 
alkenes and stabilized azomethine ylides generated from 
prolinates, following the typical iminium route (Scheme 1, 
eq. a) [7,8], or even following a generation of non-stabilized 
azomethine ylide through a decarboxylative route employing 
proline (Scheme 1, eq. b and c). This last route allowed the 
synthesis of complex skeletons when proline and isatine 
were involved in the process [9] In this sense, Felluga et al. 
also described a three component decarboxylative 
diastereoselective 1,3-DC version using (2S,4R)-4-
hydroxyproline and 2,3-butanedione or ethyl pyruvate with 
β-nitrostyrene to give, at room temperature, mixtures of 
diastereomeric pyrrolidines in good yields (78-90%) (Scheme 
1, eq. c). [10] 
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Scheme 1. Pyrrolizidine synthesis from azomethine ylides 
generated by the iminium route or by decarboxylation of 
proline derivatives. 
 
To the best of our knowledge, this is the sole publication 
in which a chiral proline derivative was employed for the 
preparation of pyrrolizidines. So, according to our experience 
in the preparation of enantiomerically enriched 
pyrrolizidines, following the route depicted in eq. a) of 
Scheme 1 from enantiomerically enriched prolinates [7c], we 
decided to study the diastereoselective multicomponent 
decaboxylative 1,3-DC using enantiomerically pure 
nitroprolinate exo-1, aldehydes or ketones and electrophilic 
alkenes. So, the synthesis of polysubstituted non-
hydroxylated pyrrolizidines will be surveyed.   
 
The selection of this starting pyrrolidine 1 bearing a nitro 
group [11] is due to the recent importance of nitroprolinates 
as useful tools in organic synthesis as organocatalysts 
[12,13,14], chiral ligands [12,15,16], and chiral building 
blocks [17,18]. Their biological properties are very 
interesting: for example, it was found a family of inhibitors of 
α4,β1-integrin-mediated hepatic melanoma and in a murine 
model of colon carcinoma metastasis, as well as potent 
antiadhesive properties in several cancer cell lines [19,20]. 
Several compounds acted as inhibitors of skin cancer [21], 
they can increase the mortality of zebrafish embryos [22], 
and a series of nitroprolinates were successfully tested as 
antimycobacterials against M. tuberculosis H37Rv strain 
[23,24,25]. Besides, the nitro group can be easily 
transformed in several functional groups and it has been 
found as the responsible atomic arrangement of 
stereodivergent cycloaddition processes [18].  
 
2. RESULTS AND DISCUSSION 
Enantioenriched methyl 4-nitro-3,5-diphenylprolinate 
(exo-2), prepared by enantioselective catalytic 1,3-DC of 
methyl benzylideneglycinate with β-nitrostyrene, in the 
presence of a chiral phosphoramidite·AgOBz complex (5 
mol%) in >99:1 er (>99:1 exo:endo dr) [26,27], was allowed 
to react through a hydrolytic process (Scheme 2). Proline 
derivative exo-1 was obtained in 85% yield by treatment with 
sodium hydroxide in a 1:1 water:acetone [14] solution at 
room temperature during 16 h.  
 
 
Scheme 2. Synthesis of proline derivative exo-1. 
Next, the multicomponent 1,3-DC between nitroproline 
exo-1, cinnamaldehyde and N-methylmaleimide (NMM) was 
studied (Scheme 3, Table 1). Toluene was selected as solvent 
because it was the most appropriate in previous articles 
regarding [3+2] [7b,c] or [4+2] [18] cycloadditions involving 
prolinates. Temperature was the main parameter to be 
implemented for achieving the maximum conversion. The 
decarboxylation of the iminium salt formed between exo-1 
and cinnamaldehyde occurred at room temperature as well 
as the successive cycloaddition with NMM (Table 1, entry 1). 
In this case, a mixture of diastereoisomers endo-3a:endo-4a 
was obtained in 40:60 ratio and in excellent 90% overall yield. 
The conversions of this reaction decreased when lower 
temperatures (10 °C or 0 °C) were assayed. N-
Phenylmaleimide (NPM) was tested under the same reaction 
conditions affording a 1:1 mixture of inseparable endo-3b 
and endo-4b adducts in 81% overall yield (Table 1, entry 2). 
However, when N-(5-bromophenyl)maleimide was used a 
total diastereoselection was observed after analyzing the 1H 
NMR spectra of the crude material. Product endo-3c was 
isolated in 80% yield (Table 1, entry 3).  
Dimethyl fumarate was found to be an appropriate 
dipolarophile because total diastereoselection was observed 
giving endo-3d. The temperature of the multicomponent 
sequence was 25 °C as well, in short reaction time (6 h) and 
in good 76% yield (Table 1, entry 4). A similar chemical yield 
was achieved when 1,2-bis(phenylsulfonyl)ethylene (BPSE) 
was employed as dipolarophile under the same reaction 
conditions, but the diastereoselection was lower obtaining 
an 70:30 mixture of presumed endo-3e:endo-4e and endo-3e 
could be isolated in 50% yield allowing the configuration 
assignment (Table 1, entry 5).  
When other aldehydes, different to cinnamaldehyde, 
were studied, namely benzaldehyde or 
dihydrocinnamaldehyde, longer reaction time (17 h) and 
higher temperature (70 °C) were needed. The 
diastereoselection of the reaction with different 
dipolarophiles regarding benzaldehyde and dimethyl 
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fumarate was very low obtaining a 66:34 endo-3f:endo-4f 
ratio in 84% overall yield (Table 1, entry 6). In both examples 
performed with dihydrocinnamaldehyde 65:35, inseparable 
mixture of the corresponding products endo-3g:endo-4g and 
endo-3h:endo-4h were isolated in 23% and 26% overall 
yields, respectively (Table 1, entries 7 and 8).  
4-Phenyl-3-buten-2-one also formed a reactive 
azomethine ylide after decarboxylation, ready to react with 
NMM and dimethyl fumarate (Table 1, entries 9 and 10). The 
highest both diastereoselection and chemical yield was 
obtained with NMM (only endo-3i was isolated, 47% yield) 
meanwhile dimethyl fumarate furnished an unpurified 
pyrrolizidine endo-3j in 30% yield.  
 
 
Scheme 3. Multicomponent diastereoselective 1,3-DC 
with exo-1, aldehydes/ketones and dipolarophiles. 
 
 
Table 1. Synthesis of nitropyrrolizidines endo-3 and endo-4. 
 
Entry R3-CO-R4 Dipolarophile time (h) T (°C) Product Structure, Ratio, Yield (%) a  
1 
 
NMM 6 25 
 
      endo-3a (36%)                      endo-4a (54%) 
2 
 
NPM 6 25 
 
             endo-3b         (50: 50)            endo-4b  
                                (overall 81%)b 
3 
 
N(4-Br-)PM 6 25 
 
                  endo-3c  (80%) 
4 
 
Dimethyl 
fumarate 
6 25 
 
          endo-3d  (76%) 
5 
 
BPSE 6 25 
 
              endo-3e         (70:30)              endo-4e 
                                 (overall 71%)b 
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6 PhCHO Dimethyl 
fumarate 
17 70 
 
            endo-3f         (66:34)         endo-4f 
                              (overall 84%) 
7 
 
NMM 17 70 
 
          endo-3g          (35:65)              endo-4g  
                              (overall 23%) 
8 
 
Dimethyl 
fumarate 
17 70 
 
            endo-3h          (65:35)            endo-4h    
                                (overall 26%) 
9 
 
NMM 24 80 
 
               endo-3i (47%) 
10 
 
Dimethyl 
fumarate 
24 80 
 
               endo-3j  (30%) 
a Isolated yield after flash chromatography. 
b Compound endo-3e was isolated in 50% yield. 
 
 
According to several NMR bidimensional experiments, 
especially NOESY and individual signal irradiations (Figure 2), 
the represented structures of the Table 1 were assigned. In 
the examples performed with NMM the two observed 
diastereoisomers could be separated. The endo-4a shown 
nOe between H(4)-H(5) and H(6)-H(7) but any increment of 
residual population was detected between H(3)-H(4) unlike 
to the very intense nOe observed in the case of product endo-
3a. In this last molecule, nOe of H(4)-H(5) and H(6)-H(7) were 
also representative. In the reaction dealing with 
cinnamaldehyde and dimethyl fumarate the resulting pure 
cycloadduct endo-3d showed very intense nOe  H(3)-H(4), 
H(4)-H(5) and H(5)-H(7) and a significant negative nOe H(6)-
H(7) (see, supporting information for the analysis of NMR 
experiments of the other molecules). 
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Figure 2. Most representative nOe in molecules endo-4a, 
endo-3a and endo-3d. 
With all these data in hand, the absolute configuration of 
the resulting compounds revealed that two possible endo-
approaches towards dipole I are the responsible of the 
reaction course, that means, the endoup and the endodown 
afforded cycloadducts endo-3 and endo-4, respectively. For 
the example of NMM, the major diastereoisomer endo-4a 
corresponded to the endodown reaction pathway (Scheme 4). 
Analyzing our previous experience with the stabilized 
azomethine ylide II, the major or exclusive endodown approach 
occurred, through the less hindered part of the dipole [7bc], 
but now the absence of the methoxycarbonyl group of the 
pyrrolidine ring facilitated the reaction by this upper face by 
the NMM eluding the stereoelectronic interaction with the 
nitro group. In cycloadduct endo-3a the 1H NMR signal of the 
methyl group bonded to the nitrogen atom is shielded due to 
the proximity to the center of the aromatic electronic cloud 
(see the analogy with Figure 3 but anchoring a methyl group 
instead a phenyl substituent in the maleimide part). 
However, the methyl group in endo-4a is deshielded with 
respect to the corresponding one of the endo-3a around 0.5 
ppm.  
 
   
 
Scheme 4. Two possible endo approaches of NMM to the 
non-stabilized azomethine ylide I. 
 
The approach of the NMM to the corresponding dipoles 
generated by dihydrocinnamaldehyde followed the same 
trend obtaining endo-4g cycloadduct as major isomer. This 
idea was supported by the chemical shift observed for the 
methyl group bonded to the nitrogen atom (see above). With 
phenyl-3-buten-2-one, the nature of the dipole is different 
and also it is much more hindered giving access to a unique 
diastereoisomer as a consequence of a endoup attack.  
However, when the substituent of the nitrogen atom of 
the maleimide is an aromatic group the diastereoselection is 
partially displaced to a 1:1 diastereomeric endo-3b:endo-4g, 
mixture in the example run in the presence of NPM, or totally 
displaced (only one diastereoisomer endo-3c was obtained) 
in the case of working with N-(4-bromophenyl)maleimide. 
Using very simple calculations [28] the presence of these 
aromatic rings in maleimides favor a strong π-interaction 
between them and the phenyl ring allocated in C(3) and a 
very weak π-interaction with the phenyl group of the 
cinnamyl residue (Figure 3). It seems that the electronic 
inductive effect of the bromine atom increases the attraction 
of the two aryl moieties. The possible intense electronic 
repulsions of the nitro group with this bulkier maleimides is 
another important detail to remark. 
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Figure 3. Possible π-interactions favoring the endoup 
approach for the reactions involving N-arylmaleimides. 
 
When dimethyl fumarate was employed as dipolarophile, 
it was expected two possible endo-approaches as deduced 
for the behavior of NMM in Scheme 4. The exclusive 
diastereoisomer isolated and fully characterized endo-3d, 
indicated that the preference of the endoup pathway would 
be only possible (confirmed by nOe results depicted in Figure 
2). The lower energy calculated for endoup approach also 
supports the presence of this unique diastereoisomer (Figure 
4). These two combined data were also very interesting in 
order to clarify the exact position of the negative charge of 
the dipole I, which triggers the Michael-type addition (1st 
step) with simultaneous Mannich type reaction. This 
negative charge was better stabilized by the allylic system 
rather than in the inner part of the cycle matching with the 
stereochemical outcome observed. This model can be 
extended to other cycloadducts derived from dimethyl 
fumarate and also from BPSE.  
 
 
  
Figure 4. Minimun energy of endo-cycloadducts endo-3d 
and endo-4d and proposed geometry of the intermediate 
1,3-dipole. 
 
 
3. EXPERIMENTAL SECTION 
3.1. General 
3.2. (2S,3S,4R,5S)-4-Nitro-3,5-diphenylpyrrolidine-2-
carboxylic acid, exo-1 [14]  
To a suspension of the polisubstituted proline (400 mg, 1.23 
mmol) in 5 mL of acetone was added dropwise sodium 
hydroxide (120 mg, 3 mmol) in 5 mL of water. The resulting 
mixture was stirred for 16 h. Then, the solution was cooled 
to 5 ᵒC and treated with hydrochloric acid 2 M to pH 2 
obtaining the desired product as a precipitate. After filtration 
and washing with water a yellow pale solid was afforded (326 
mg, 1.04 mmol). [𝛼]𝐷
26 = 82.1 (c 1, acetone),14 [𝛼]𝐷
26(exp.) = 
61.4 (c 1, acetone); 1H NMR (300 MHz, CDCl3): δ 4.54-4.66 
(m, 2H, NCHCO2H, NCHCHPh), 4.93 (d, J = 8.6, NCHPh), 6.46 
(t, J = 8.6, CHNO2) 7.28-7.68 (m, 10H, ArH) ppm. 
3.3. General procedure for the synthesis of pyrrolizidines 
3 and 4.  
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To a suspension of the corresponding polisubstituted proline 
exo-1 (100 mg, 0.32 mmol) in toluene was added dropwise 
the corresponding aldehyde or ketone (1 equiv.). After 5 
minutes was added the dipolarophile (1.1 equiv.) and the 
reaction mixture was checked by TLC (hexane:ethyl acetate, 
8:2). The resultant solution was dried under vacuum and the 
crude residue was purified by column chromatography 
(hexane:ethyl acetate, 8:2). Time and temperatures of the 
different reaction are collected in the table. 
 
3.3.1 (3aR,4R,6S,7R,8S,8aS,8bS)-2-Methyl-7-nitro-6,8-
diphenyl-4-((E)-styryl)hexahydropyrrolo[3,4-
a]pirrolizine-1,3(2H,8bH)-dione, endo-4a  
White solid (hexane/ethyl acetate). Yield 54%. Melting 
Point: 191-193 °C; [𝛼]𝐷
26 = -41.6 (c 1, CHCl3); IR (ATR):  1695, 
1552, 1494, 1432 cm-1. 1H NMR (300 MHz, CDCl3): δ 3.04 (s, 
3H, NCH3), 3.34 (d, J = 8.2 Hz, 1H, C=CCHCHCH), 3.68 (dd, J = 
10.6, 5.7 Hz, 1H, C=CCHCH), 4.12 (dd, J = 10.9, 8.6 Hz, 1H, 
NCHCHPh), 4.24 (d, J = 10.9 Hz, 1H, NCHCHPh), 4.46 (t, J = 8.1 
Hz, 1H, NCHC=C), 4.75 (d, J = 4.4 Hz, 1H, NCHPh), 5.20 (dd, J 
= 8.5, 4.5 Hz, 1H, CHNO2), 6.16 (dd, J = 15.7, 8.0 Hz, 1H, 
PhCH=CH), 6.68 (d, J = 15.7 Hz, 1H, PhCH=CH) 7.08-7.41 (m, 
15H, ArH) ppm; 13C NMR (CDCl3): δC 25.7 (NCH3), 48.0 
(C=CCHCHCH), 49.1 (C=CCHCH), 56.1 (NCHCHPh), 68.7 
(NCHC=C), 70.7 (NCHPh), 73.0 (NCHCHPh), 102.9 (CH3NO2), 
125.6 (PhCH=CH), 126.3, 127.2, 127.7, 128.3, 128.4, 128.9, 
129.4, 129.8 (ArC), 134.8 (PhCH=CH), 135.6, 136.5, 140.5 
(ArC) 175.4 (NCO), 177.4 (NCO) ppm; MS (EI): m/z 493 (M+- 
NO2, 2%), 460 (12), 459 (33), 457 (16), 451 (27), 450 (100), 
444 (80), 436 (33), 429 (32), 428 (69), 427 (26), 370 (12), 343 
(30), 341 (59), 268 (17), 267 (13), 256 (63), 255 (79), 253 (77), 
193 (80), 168 (72), 116 (20), 115 (93), 105 (69), 77 (43); HRMS 
(DIP) calcd. for C30H27N3O4 493.2002, found 493.1889. 
 
3.3.2 (3aS,4S,6S,7R,8S,8aR,8bR)-2-Methyl-7-nitro-6,8-
diphenyl-4-[(E)-styryl]hexahydropyrrolo[3,4-
a]pyrrolizine-1,3(2H,8bH)-dione, endo-3a 
Brown oil. Yield 36%. [𝛼]𝐷
28 = -23.3 (c 1.2, CHCl3). IR (ATR):  
1697, 1550, 1492, 1434 cm-1. 1H NMR (300 MHz, CDCl3): δ 
3.18 (s, 3H, NCH3), 3.44 (dd, J = 8.3, 1.9 Hz, 1H, C=CCHCHCH), 
3.63 (t, J = 8.5 Hz, 1H, C=CCHCH), 4.30 (m, 3H, NCHCHPh, 
NCHCHPh, NCHC=C), 4.33-4.36 (m, 1H, NCHPh), 4.98 (t, J = 
8.2 Hz, 1H, CHNO2), 6.1 (dd, J = 15.8, 5.1 Hz, 1H, PhCH=CH), 
6.68 (dd, J = 15.8, 1.6 Hz, 1H, PhCH=CH), 7.30-7.41 (m, 15H, 
ArH) ppm. 13C NMR (CDCl3): δ 15.4 (NCH3), 49.5 
(C=CCHCHCH), 52.2 (C=CCHCH), 60.51 (NCHCHPh), 65.6 
(NCHC=C), 70.6 (NCHPh), 70.81 (NCHCHPh), 91.7 (CH3NO2), 
127.4, 127.8, 127.9, 128.6, 129.1, 129.2, 129.5, 130.34, 
132.0, 133.2, 135.0, 163.5, 169.3 (PhCH=CH, PhCH=CH, ArC), 
169.5 (CO) 179.2 (CO) ppm. MS (EI): m/z 493 (M+- NO2, 2%), 
460 (12), 459 (33), 457 (16), 451 (27), 450 (100), 444 (80), 436 
(33), 429 (32), 428 (69), 427 (26), 370 (12), 343 (30), 341 (59), 
268 (17), 267 (13), 256 (63), 255 (79), 253 (77), 193 (80), 168 
(72), 116 (20), 115 (100), 105 (69), 77 (43). HRMS (DIP) calcd. 
for C30H27N3O4 493.2002, found 493.1889. 
 
3.3.3 (3aR,4R,6S,7R,8S,8aS,8bS)-7-Nitro-2,6,8-
triphenyl-4-[(E)-styryl]hexahydropyrrolo[3,4-
a]pyrrolizine-1,3(2H,8bH)-dione endo-4b and 
(3aS,4S,6S,7R,8S,8aR,8bR)-7-nitro-2,6,8-triphenyl-4-[(E)-
styryl]hexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-
dione, endo-3b 
Yellow oil. Yield 81%. IR (ATR):  1720, 1550 cm-1. 1H NMR 
(300 MHz, CDCl3): (1:1) mixture of diastereoisomers: δ 3.49 
(dd, J = 8.3, 1.3 Hz, 1H), 3.58 (dd, J = 8.6, 1.7 Hz, 1H), 3.74 (t, 
J = 8.9 Hz, 1H), 3.83 (t, J = 8.3 Hz, 1H), 4.16 (dd, J = 10.6, 8.6 
Hz, 1H), 4.33-4.57 (m, 6H), 4.79 (d, J = 4.6 hz, 1H), 5.06 (dd, J 
= 10.7, 6.7 Hz, 1H), 5.22 (dd, J = 8.5, 4.7 Hz, 1H), 6.11 (dd, J = 
15.8, 4.9 Hz, 1H), 6.23 (J = 15.7, 7.6 Hz, 1H), 6.72 (dd, J = 15.8, 
1.7 Hz, 1H), 6.74 (d, J = 15.7 Hz, 1H), 7.19-7.60 (m, 40H) ppm. 
13C NMR (CDCl3): δ 29.7, 48.3, 48.8, 50.2, 50.4, 53.8, 55.9, 
65.1, 68.4, 70.5, 72.3 72.4, 73.0, 98.7, 102.5 ppm. MS (EI): 
m/z 510 (M+, 4%), 509 (38), 450 (13), 436 (21), 378 (36), 334 
(60), 329 (22), 317 (15), 316 (24), 282 (30), 258 (70), 232 (44), 
190 (100), 115 (25); HRMS (DIP) calcd. for 555.22, found 
555.22. 
 
3.3.4 (3aR,4R,6S,7R,8S,8aS,8bS)-2-(4-Bromophenyl)-
7-nitro-6,8-diphenyl-4-[(E)-styryl]hexahydropyrrolo[3,4-
a]pirrolizine-1,3(2H,8bH)-dione, endo-3c 
Pink oil. Yield 80%. [𝛼]𝐷
28 = -92.3 (c 1, CHCl3). IR (ATR): 
2921, 2851, 1710, 1546, 1491 cm-1. 1H NMR (300 MHz, 
CDCl3): δ 3.49 (dd, J = 8.3, 1.3 Hz, 1H, C=CCHCHCH), 3.85 (t, J 
= 8.3 Hz, 1H, C=CCHCH), 4.15 (dd, J = 10.5, 8.6 Hz, 1H, 
NCHCHPh), 4.35 (d, J = 10.6 Hz, 1H, NCHCHPh), 4.56 (t, J = 7.7 
Hz, 1H, NCHC=C), 4.78 (d, J = 4.7 Hz, 1H, NCHPh), 5.22 (dd, J 
= 8.5, 4.7 Hz, 1H, CHNO2), 6.21 (dd, J = 15.7, 7.5 Hz, 1H, 
PhCH=CH), 6.74 (d, J = 15.7 Hz, 1H, PhCH=CH) 7.14-7.57 (m, 
15H, ArH) ppm. 13C NMR (CDCl3): δ 48.6 (CHPhCHCHCO), 49.0 
(C=CHCHCHCO) 56.1 (NCHCHPh), 68.6 (C=CHCH), 70.9 
(NCHPh), 73.2 (NCHCHPh), 102.5 (CHNO2), 122.9 (PhCH=CH), 
134.6 (PhCH=CH), 125.2, 126.2, 127.1, 127.6, 128.1, 128.4, 
128.8, 129.4, 132.6, 135.6, 136.2, 140.2 (ArC), 174.1 (NCO), 
176.0 (NCO) ppm. MS (EI): m/z 586 (M+-NO2, 40%), 584 (37), 
571 (32), 570 (98), 569 (48), 568 (93), 567 (16), 482 (23), 480 
(16), 396 (15), 394 (21), 343 (24), 256 (30), 255 (32), 254 (22), 
239 (17), 219 (19), 193 (64), 178 (18), 168 (67), 167 (30), 165 
(16), 154 (18), 141 (17), 128 (17), 117 (30), 116 (27), 115 
(100), 91 (50), 90 (24), 89 (26), 77 (43), 63 (17). HRMS (DIP) 
calcd. for C36H29N3O4(–NO2) 586.1141, found 586.1108. 
 
3.3.5 (1R,2R,3S,5S,6R,7S,7aR)-Dimethyl 6-nitro-5,7-
diphenyl-3-[(E)-styryl]hexahydro-1H-pyrrolizine-1,2-
dicarboxylate, endo-3d 
White solid (hexane/ethyl acetate). Yield 76%. Melting 
Point: 148-154.  [𝛼]𝐷
26 = -28.3 (c 1, CHCl3). IR (ATR):  1734, 
1550, 1495, 1437 cm-1. 1H NMR (300 MHz, CDCl3): δ 3.49 (dd, 
J = 12.6, 10.5 Hz, 1H, C=CCHCH), 3.51 (s, 3H, CO2CH3), 3.66 
(dd, J = 9.8, 7.5 Hz, 1H, C=CCHCHCH), 3.73 (s, 3H, CO2CH3),  
4.0-4.19 (m, 2H, NCHCHPh, NCHCHPh), 4.30 (t, J = 7.1 Hz, 1H, 
NCHC=C), 4.72 (d, J = 8 Hz, 1H, NCHPh), 5.16 (t, J = 8.6 Hz, 1H, 
CHNO2), 6.03 (dd, J = 15.7, 7.4 Hz, 1H, PhCH=CH), 6.41 (d, J = 
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15.8 Hz, 1H, PhCH=CH) 7.18-7.47 (m, 15H, ArH) ppm; 13C NMR 
(CDCl3) δC: 51.2 (OCH3), 52.3 (OCH3), 52.6 (NCHCHPh), 55.0 
(C=CCHCH o C=CCHCHCOCH), 56.0 (C=CCHCH o 
C=CCHCHCOCH), 71.2 (NCHC=C), 71.5 (NCHPh), 72.6 
(NCHCHPh), 99.9 (CHNO2), 126.6, 127.3, 127.5, 127.9, 128.3, 
128.5, 128.9, 128.9, 129.2, 133.0, 136.1 (PhCH=CH, 
PhCH=CH, ArC), 171.2 , 172.0 (CO) ppm. MS (EI): m/z 480 (M+ 
-NO2, <2%), 376 (12), 344 (16), 194 (15), 193 (100), 178 (12), 
115 (53), 105 (25). HRMS (DIP) calcd. for C26H25N3O6(–NO2) 
480.2175, found 480.2179. 
 
3.3.6 (1S,2R,3S,5S,6R,7R,7aR)-2-nitro-1,3-diphenyl-
6,7-bis(phenylsulfonyl)-5-[(E)-styryl]hexahydro-1H-
pyrrolizine, endo-3e 
Brown oil. Yield 50%. [𝛼]𝐷
28 = 22.3 (c 1.2, CHCl3). IR (ATR):  
1730, 1548, 1494, 1448 cm-1. 1H NMR (300 MHz, CDCl3): δ 
3.75 (m, 1H, NCHCHPh), 4.11 (m,  1H, CHS), 4.47  (t, J = 12.1 
Hz, 1H, NCHCHPh), 4.79 (dd, J = 14.4, 9.0 Hz, 1H, CHS), 5.24 
(m, 1H, NCHPh), 5.47 (dd, J = 12.2, 8.0 Hz, 1H, CHNO2), 5.81 
(d, J = 7.4 Hz, 1H,  PhCH=CH), 6.11 (d, J = 8.2 Hz, 1H, 
PhCH=CH), 7.12-7.45 (m, 25H, ArH) ppm. 13C NMR (CDCl3): δ 
46.3 (NCHCHPh), 48.3 (CSO2Ph), 50.6 (CSO2Ph), 55.5 
(CSO2Ph), 64.4 (NCHCHPh), 64.4 (C=CCH), 68.7 (NCHPh), 95.2 
(CHNO2), 96.16, 125.4, 126.8, 127.0, 127.1, 127.3, 127.8, 
128.0, 128.6, 128.7, 128.8, 129.0, 129.0, 129.1, 129.3, 129.5, 
129.6, 129.7, 129.7, 130.0 (ArC, PhCH=CH, PhCH=CH)  ppm. 
MS (EI): m/z 644 (M+-NO2, 3%), 194 (35), 193 (100), 178 (14), 
168 (17), 115 (52), 91 (15). HRMS (DIP) calcd. for 
C26H25N3O6(–C6H5SNO4) 503.1919, found 503.1901. 
 
3.3.7 (1S,2S,3R,5S,6R,7S,7aR)-dimethyl 6-nitro-3,5,7-
triphenylhexahydro-1H-pyrrolizine-1,2-dicarboxylate 
(major), endo-3f 
Blue oil. Yield 84%. IR (ATR):  1733, 1552, 1492, 1436 cm-1. 
1H NMR (300 MHz, CDCl3): 64:44 mixture of 
diastereoisormers: δ 3.08 (s, 1.5H, CH3), 3.42 (s, 1.5H, CH3), 
3.53 (s, 3H, CH3), 3.60 (dd, J = 9.5, 8.4 Hz, 1H, 
PhCHCHCOCHCO), 3.69 (s, 3H, CH3), 3.72 (dd, J = 9.6, 7.2 Hz, 
1H, PhCHCHCO), 3.80 (dd, J = 11.3, 8.5 Hz, 0,5H, PHCHCHCO), 
3.96 (t, J = 10.4 Hz, 0,5H, PhCHCHCOCHCO), 4.21 (t, J = 7.7 Hz, 
1H, NCHCHPh), 4.31 (t, J = 7.4 Hz, 1H, NCHCHPh), 4.48 (d, J = 
8.4 Hz, 1H, PhCHCHCO), 4.57-4.75 (m, 1.5H, NCHCHPh, 
PhCHCHCO, NCHPh), 4.71 (d, J = 7.6 Hz, 1H, NCHPh), 4.93 (d, 
J = 10.3, 7.9 Hz, 0.5H, CHNO2) 5.12 (dd, J = 8.9, 7.7 Hz, 1H, 
CHNO2), 7.18-7.38 (m, 22.5H, ArH) ppm. 13C NMR (CDCl3): δ 
46.9, 49.8, 51.5, 51.9, 52.4, 52.6, 52.7, 53.4, 56.1, 57.7, 69.1, 
70.0, 72.8, 73.6, 73.7, 99.7 (CHNO2), 100.8 (CHNO2), 125.5, 
126.6, 127.1, 127.2, 127.6, 127.8, 127.9, 128.0, 128.3, 128.5, 
128.6, 128.8, 129.0, 129.1, 129.3, 129.6, 135.4, 137.3, 138.9, 
139.4, 140.3, 170.3 (C=O), 170.9 (C=O), 171.8 (C=O), 172.8 
(C=O) ppm. MS (EI): m/z 454 (M+-NO2, 26%), 308 (19), 232 
(20), 195 (24), 194 (15), 194 (100), 193 (16), 191 (38), 179 
(20), 178 (85), 165 (23), 129 (15), 128 (17), 116 (71), 115 (94), 
91 (76), 77 (21). HRMS (DIP): calcd. for C26H25N3O6(–NO2) 
480.2018, found 454.2027. 
 
3.3.8 (4S,6S,7R,8S,8aR)-2-Methyl-7-nitro-4-
phenethyl-6,8-diphenylhexahydropyrrolo[3,4-
a]pyrrolizine-1,3(2H, 8bH)-dione (major) endo-4g and 
(3aR,4R,6S,7R,8S,8aS,8bS)-2-methyl-7-nitro-4-
phenethyl-6,8-diphenylhexahydro-pyrrolo[3,4-
a]pyrrolizine-1,3(2H,8bH)-dione (minor),  endo-3g 
Yellow oil. Yield 23%. IR (ATR): 1728, 1536, 1489 cm-1. 1H 
NMR (300 MHz, CDCl3): δ (diastereoisomers mixture 
(1.0:0.6)): 1.73 (m, 3.2H), 2.37 (m, 1.2H), 2.70 (m, 1.6H), 2.92 
(m, 0.6H), 3.02 (s, 1.3 H), 3.21 (d, J = 8.3 Hz, 1H), 3.39 (m, 
0.6H), 3.56-3.74 (m, 3H), 4.00 (dd, J = , 0.6H), 4.09 (s, 0.6H), 
4.24-4.33 (m, 2.2H), 4.6 (d, J = 5.8 Hz, 0.6H), 5.02 (dd, J = 8.8, 
7.9 Hz, 1H), 5.10 (dd, J = 8.5, 5.8 Hz, 1H) ppm. 13C NMR 
(CDCl3): δ 25.2, 25.6, 32.7, 32.8, 33.0, 37.6, 47.2, 49.7, 50.1, 
53.1, 55.3, 64.3, 71.5, 72.0, 72.8, 96.7, 126.0, 126.4, 127.5, 
128.0, 128.2, 128.4, 128.5, 129.1, 129.4, 129.4, 129.5, 141.1, 
141.4, 177.3, 178.7 ppm. MS (EI): m/z 495 (M+, 5%), 449  (33), 
421 (10), 405 (20), 391 (60), 390 (80), 371 (48), 357 (41), 344 
(22), 343 (43), 336 (14), 270 (15), 190 (100), 152 (45), 115 
(20), 70 (12). HRMS (DIP) calcd. 495.22, found 495.22. 
 
3.3.9 Dimethyl 2,2'-[(1S,2S,3R,5S,6R,7S,7aS)-6-nitro-
3-phenethyl-5,7-diphenylhexahydro-1H-pyrrolizine-1,2-
diyl]bis(2-oxoacetate) endo-3h (major) and dimethyl 
2,2'-[(1R,2R,3S,5S,6R,7S,7aR)-6-nitro-3-phenethyl-5,7-
diphenylhexahydro-1H-pyrrolizine-1,2-diyl]bis(2-
oxoacetate) endo-4h 
Pink oil. Yield. 26%. IR (ATR): 2832, 1731, 1533, 1494 cm-1. 
1H NMR (300 MHz, CDCl3): 65:35 mixture of diastereoisomer: 
δ 1.62-1.82 (m, 2.6H, CH2), 2.37-2.63 (m, 2.6H, CH2), 3.23 (s, 
1.3H) 3.34-3.37 (m, 2.2H, CH2CH, CHCO2Me), 3.60 (s, 3H, 
CO2Me), 3.78 (s, 3H, CO2Me), 3.76-3.80 (m, 2H, CHCO2Me, 
NCHCHPh), 4.00 (dd, J = 9.0, 5.2 Hz, 1H, NCHCHPh), 4.57 (d, J 
= 8.6 Hz, 1H, NCHCHPh), 5.04 (t, J = 8.6 Hz, 1H, CHNO2). 13C 
NMR (CDCl3): 31.6, 23.3, 33.4, 37.2, 51.6, 52.3, 52.7, 53.4, 
53.7, 54.8, 65.3, 67.7, 73.2, 74.0, 74.3, 89.3, 100.3, 125.9, 
127.2, 127.6,2, 127.5, 127.9, 128.0, 128.0, 128.1, 128.3, 
128.4, 128.4, 129.0, 129.1, 129.2, 129.3, 129.6, 138.2, 139.1, 
141.6, 171.3, 171.4, 172.3, 173.7 ppm. MS(EI): m/z 528 (M+, 
2%), 482 (64), 469 (12), 423 (100), 410 (32), 402 (12), 384 
(10), 314 (18), 195 (21), 118 (19), 114 (64). HRMS (DIP): calcd. 
for 528.3311,  found 528.3311.  
 
3.3.10 (6S,7R,8S,8aR)-2,4-dimethyl-7-nitro-4-
phenethyl-6,8-diphenylhexahydropyrrolo[3,4-
a]pyrrolizine-1,3(2H,8bH)-dione, endo-3i 
Brown oil. Yield 47%. [𝛼]𝐷
25 = 102.3 (c 1, CHCl3). IR (ATR):  
1733, 1551, 1494 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.48 (s, 
1H, CH3), 3.03 (s, 3H, NCH3), 3.37 (d, J = 8.2 Hz, 1H, CCHCO), 
3.58 (t, J = 8.7 Hz, 1H, NCHCHCO), 4.35 (t, J = 8.5 Hz, 1H, 
NCHCHPh), 4.55 (dd, J = 9.0, 7.9 Hz, 1H, NCHCHPh), 4.73 (d, J 
= 7.6 Hz, 1H, NCHPh), 4.95 (dd, J = 8.9, 7.7 Hz, 1H, CHNO2)  
6.19 (d, J = 16.1Hz, 1H, PhCH=CH), 6.42 (d, J = 16.1 Hz, 1H, 
PhCH=CH), 7.07-7.41 (15H, ArCH) ppm. 13C NMR (CDCl3): δ 
25.0 (CH3), 26.5 (CH3), 48.3 (CH), 51.8 (CH), 59.1 (CH), 67.4 
(CH), 68.0 (CH), 71.6 (CH), 101.9 (CH), 122.8, 126.3, 126.5, 
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127.6, 128.0, 128.0, 128.3, 129.1, 132.7, 136.1, 138.3, 140.7 
(ArC, PhCH=CH, PhCH=CH), 175.3 (CO), 176.5 (CO) ppm. MS 
(EI): m/z 507 (M+, 5%), 492 (38), 461 (68), 430 (23), 404 (55), 
396 (14), 359 (100), 274 (21), 193 (30), 80 (12). HRMS (DIP): 
calcd. for 507.2203, found 507.2203.  
 
3.3.11 dimethyl 2,2'-((1S,2S,3R,5S,6R,7S,7aS)-3-
methyl-6-nitro-5,7-diphenyl-3-((E)-styryl)hexahydro-1H-
pyrrolizine-1,2-diyl)bis(2-oxoacetate), endo-3j 
Blue oil. Yield 30%. [𝛼]𝐷
28 = 70.2 (1c, CHCl3). IR (ATR): 2831, 
1730, 1542, 1467 cm-1. 1H NMR (300 MHz, CDCl3): δ 1.36 (s, 
3H, CCH3), 3.28 (s, 3H, CO2CH3), 3.59 (s, 3H, CO2CH3), 3.65-
3.74 (m, 2H, CHCO2Me,CHCO2Me), 3.96 (t, J = 10.6 Hz, 
NCHCHPh), 4.23 (dd, J = 9.9, 8.3 Hz, 1H, NCHCHPh), 4.86 (d, J 
= 8.2 Hz, 1H, NCHPh), 5.07 (dd, J = 10.6, 8.2 Hz, 1H, CHNO2), 
6.34 (d, J = 16,1 Hz, 1H, CH=CH), 6.41 (d, J = 16,1 Hz, 1H, 
CH=CH), 7.23-7.44 (m, 15H, ArH) ppm. 13C NMR (CDCl3): δ 
25.5 (CCH3), 49.9 (C), 52.0 (OCH3), 52.4 (OCH3), 58.9 
NCHCHPh), 60.3 (CHCO2CH3), 60.9 (CHCO2CH3), 67.0 
(NCHCHPh), 72.2 (NCHPh), 101.2 (CHNO2), 126.9, 126.9, 
127.6, 128.3, 128.4, 128.5, 128.9, 128.9, 129.0, 129.3, 129.6, 
133.8, 135.4, 136.4, 141.0 (ArC, PhCH=CH, PhCH=CH), 171.3 
(CO2CH3), 172.2 (CO2CH3). MS (EI): m/z 596 (M+, 5%), 525 
(34), 495 (12), 493 (82), 350 (27), 243 (100), 220 (48), 194 
(21), 193 (15), 77 (17). HRMS (DIP): calcd. for 593.6303, 
found 593.6303.  
 
 CONCLUSION 
 Enantiopure exo-4-nitro-3,5-diphenylproline reacted 
satisfactorily with aldehydes or 4-phenyl-3-buten-2-one and 
electrophilic alkenes in a multicomponent 1,3-dipolar 
cycloaddition. The decarboxylation occurred at room 
temperature but the cycloaddition took place at different 
temperatures depending on the nature of the aldehyde 
involved. The negative charge of the dipole is located at the 
allylic position such as it was depicted in Figure 4. This dipole 
reacted by its two faces also depending of the structure of the 
electrophilic alkene, but always following an endo-approach 
towards the dipole.  The preference of the attack is controlled 
by a esteroelectronic repulsion of the alkene with the nitro 
group and also by a possible π-interaction with the phenyl group 
bonded to C(3) atom. Thus, NMM attack through an endodown 
fashion except in the reaction with the unsaturated ketone, but 
N-aryl maleimides approached via endoup route. Dimethyl 
fumarate and BPSE both preferred the attack through the 
endoup manner. 
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